Our projects regularly lead to publicly accessible reports. Especially when we work for the government, government agencies or provider/professional associations. When we work for healthcare providers, health insurers or partnerships, the results of our projects are often confidential. You can find some publicly accessible reports and/or abstracts in English below. However, most of our publications are in Dutch, viewable on the Dutch website. If you would like to know more, please contact us.


14 publications found
Remove filters
Analysis of evergreening and policy options Dutch National Healthcare Institute
Publication 11 March 2024
A comparison of the regulation of the statutory healthcare package in Western Europe
Publication 12 December 2023
International lessons on emergency and acute care services reforms - webinar
Publication 28 July 2023
Output current R&D system pharmaceuticals
Publication 14 February 2023
An increasingly large piece of the pie - Forecast of expenditures on specialty drugs 2022-2026
Publication 5 July 2022
The financial ecosystem of pharmaceutical R&D
Publication 22 June 2022
A strong link - evaluation of the Good Use of Medicines programme
Publication 21 June 2022
The value of paediatric oncology
Publication 6 January 2022
Consolidating complex interventions could prevent more than 200 deaths in the Netherlands
Publication 28 July 2020
Clarification of competition rules is helpful, but not a panacea for lower prices of prescription drugs
Publication 2 January 2020
The social impact of age-related hearing impairment
Publication 19 September 2019
Aiming for the ‘high-hanging fruit’ – evaluation of the Dutch expensive medicines policy 2016-2018
Publication 4 July 2019
Tapped potential - evaluation of the Efficiency Studies programme 2006–2017
Publication 26 September 2018
Strengthening in-hospital drug purchasing
Publication 16 November 2017